Navigation Links
The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market
Date:1/27/2009

ref="http://www.rmpsi.com" target="_new">www.rmpsi.com. For more information about the company's products and services, visit http://store.rmpsi.com.

About Salus Global

Salus Global Corporation enables greater patient safety performance by healthcare professionals and their teams. Salus does this by delivering high-quality programs that identify and address the needs of those teams in improving their inter-professional learning, communication, teamwork, and culture.

Salus was created through the combined investiture of The Society of Obstetricians and Gynaecologists of Canada (SOGC) and the Healthcare Insurance Reciprocal of Canada (HIROC) the leading provider of healthcare liability insurance in Canada, This joint effort has provided the resources necessary to expand the highly successful MORE(OB) (Managing Obstetrical Risk Efficiently) and Advancing with MORE(OB) programs across Canada and in the United States. It has also enabled a nurturing environment for the continued introduction of broader patient safety programs. For more information, visit www.salusgc.com and www.moreob.com.

About FinCor Holdings

Through its subsidiaries -- FinCor Solutions, The Risk Management and Patient Safety Institute, MHA Insurance Company, Washington Casualty Company and Capital Risk Solutions, SPC -- FinCor Holdings Inc. provides industry-leading insurance products and support services, including medical professional liability insurance, workers' compensation insurance and clinical risk management solutions to clients nationally. With its years of experience focusing on financial loss protection and clinical risk reduction, FinCor Holdings has built an outstanding reputation for serving the needs of the health care industry. For m
'/>"/>

SOURCE The Risk Management and Patient Safety Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Osteotech Expands Senior Management Team; New Executives to Drive Sales Force Strategies and Therapy-Based Solutions
2. Sage Launches Sage Intergy Version 5.5 Integrated Electronic Health Records and Practice Management System
3. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Work Group (PSWG) at HL7
4. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Special Interest Group (PSSIG) at HL7
5. QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President
6. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
7. Medical Management Corporation Updates Medical Billing Services
8. MEDai Presents on Transitioning Predictive Modeling Integration From Care Management to Actuarial Applications
9. Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
10. HC Innovations Expands Management Team, Adding Vice President of Human Resources
11. Detroit Area Hospitals Seek $75 Million from United American HealthCare Arising out of its Management of the Liquidated OmniCare HMO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: ... St. George,s Hospital, University of London during a ... ("ASH") Annual Meeting updated results from the pivotal ... pixantrone (the "PIX 301 EXTEND trial") in relapsed ... who have failed 2 or more prior therapies. ...
(Date:12/6/2009)... ORLEANS and SUNNYVALE, Calif., Dec. 6 ... interim results from a Phase I/II study showing ... / recurrent non-Hodgkin,s Lymphoma (NHL) treated with its ... data were presented today at the 51st ASH ... (Abstract # 2726). ,, PCI-24781 is an ...
(Date:12/6/2009)... of feline DNA in virus , , SUNDAY, Dec. 6 (HealthDay ... might be found in a tiger that lived thousands or ... appears the virus took on a bit of a tiger,s ... remains in the virus to this day. That tiger, in ... of the virus that ultimately led to its infection of ...
(Date:12/6/2009)... Hamilton, ON. Dec. 6, 2009 A new study ... disorder known as venous thromboembolism (VTE). , The ... Americans every year, and occurs when an abnormal clot ... blood, causing pain and swelling. In some cases, the ... travel through the heart to the lungs, causing a ...
(Date:12/5/2009)... ORLEANS, Dec. 5 There have been significant scientific ... experts continue to gain a better understanding of how ... options and provide patients with the best care. Research ... American Society of Hematology explores optimal induction therapies for ...
Breaking Medicine News(10 mins):Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:AIDS May Date Back to Ancient Tiger 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8
... pulmonary arterial hypertension (PAH)chronically high blood pressure in the ... low (called hyponatremia, or HN) have a very poor ... failure (RHF), according to new research from the University ... known to indicate advanced left heart failure but has ...
... of Lower Manhattan, the terrorist attacks of September 11, ... by the Health Department,s World Trade Center Health Registry, ... had posttraumatic stress disorder (PTSD) two to three years ... residents developed PTSD at three times the usual rate ...
... Valuable Patient Care,Resources in Manner True to Their Mission, ... from Los Angeles and Orange Counties demonstrated in front ... Thursday, June 12th to protest the,firm,s anti-union tactics aimed ... System (SJHS), a $3.4 billion dollar corporation,founded by the ...
... Bipartisan Package Would Have Improved Benefits for Prevention, ... CHICAGO, June 12 Today a minority ... and improve Medicare,for the 44 million Americans who ... Providers Act, which would have improved Medicare,s,prevention, mental ...
... A University of Alberta researcher in collaboration with researchers ... come with age, at least when it comes to ... Dolcos, assistant professor of psychiatry and neuroscience in the ... help healthy older people regulate and control emotion better ...
... (NYSE: GRB ), a worldwide leader in integrated ... investors on,Thursday, June 19, 2008, at 10:00 a.m. (Eastern ... financial results and provide a Company,update. The Company will ... and full year on June 19, 2008 before the ...
Other Medicine News:Health News:Serum sodium predicts mortality 10 times higher in PAH patients 2Health News:1 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9/11 2Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 2Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 3Health News:AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill 2Health News:AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill 3Health News:New research shows how aging brain brings a healthy dose of perspective 2Health News:Gerber Scientific to Hold Fiscal Year 2008 Fourth Quarter and Full Year Conference Call 2
(Date:12/6/2009)... RNL Bio Co., Ltd, ( www.rnl.co.kr ) a ... therapeutics announced today that a 46-year-old female, Kang ... stem cell treatment. Park was suffering from MS ... central nervous system (brain and spinal cord). ... the nerves of the central nervous system degenerate. ...
(Date:12/4/2009)... 4 Thermographic Diagnostic Imaging (TDI), part of ... Jersey continues to provide superior quality infrared imaging ... and sinus regions to assist in the early ... ,, Thermography utilizes infrared imaging cameras that "read" ...
(Date:12/4/2009)... Inc. (Nasdaq: ONXX ) today announced that it ... investigators will discuss the data presentations surrounding carfilzomib in ... 51st American Society of Hematology (ASH) Annual Meeting. ,, ... ET on Monday, December 7, 2009. The live ...
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2Discover Health Through Awareness 2Discover Health Through Awareness 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Key Protein Might Shield Brain Cells 51813 1Michael Steele Chairman of the Republican National Committee Will Hold a Press Conference on Health Care the Republican Alternative at 9 am on Mon 51810 1Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer 51807 1Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer 51807 2
... about their ... risks, ... (2007), an estimated 182,460 new cases of breast,cancer will be diagnosed in ... detection of the disease when it is,more easily and successfully treated, breast ...
... Advantages ... Over Existing Once-Daily Product, NOTTINGHAM, England, ... today announced that the successful completion of preclinical,trials of ... (hGH) somatropin. Trials demonstrated therapeutic plasma,concentrations were achieved over ...
Other Medicine Technology:Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 3Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 4Critical Pharmaceuticals Enter Sustained Release hGH Arena 2
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
... Para 12 Plus is a hematology control ... 3500/3700. Assay values are provided for the ... a three-part differential on the CELL-DYN 1600 ... and closed-vial stability is 75 days. Para ...
Indicated to facilitate the intra-luminal placement of conventional guidewires beyond stenotic lesions, including chronic total coronary occlusions....
... 5X is a whole blood hematology control ... 80 and 120, and the Coulter AcT5diff ... a unique white cell differential, positioning the ... on the systems. The product offers 105-day ...
Medicine Products: